Novavax to Participate in 2024 Jefferies Global Healthcare Conference

GAITHERSBURG, Md., May 30, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the 2024 Jefferies Global Healthcare Conference. Conference Details: Contacts: Investors Erika Schultz 240-268-2022 [email protected] Media Giovanna Chandler 240-720-7804 [email protected] About Novavax | Fireside Chat | | | --- | --- | | Date: | Thursday, June 6, 2024 | | Time: | 12:30 – 12:55 p.m. Eastern Time (E ...